Recent developments in prognostic and health management have been targeted at utilizing the observed degradation signals to estimate residual life distributions. Current degradation models mainly focus on a population of “identical” devices or an individual device with population information, not a single component in the absence of prior degradation knowledge. However, the fast development of science and technology provides us with many kinds of new systems, and we just have the real-time monitoring information to analyze the reliability for them. The fusion algorithm presented herein addresses this challenge by combining the excellent modeling ability of Bayesian updating method for the multilevel data and the prominent estimation ability of ECM algorithm for incomplete data. Residual life distributions and posterior distributions are first calculated through the Bayesian updating method based on random initial a priori distributions. Then the a priori distributions are revised and improved for future predictions by the ECM algorithm. Once a new signal is observed, we can reuse the fusion algorithm to improve the accuracy of residual life distributions. The applicability of this fusion algorithm is validated by a set of simulation experiments.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2BGNbms
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Purpose Overcoming the flaws of current data management conditions in head and neck oncology could enable integrated informatio...
-
-
Vol.83 No.3 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1TkQfWM via IFTTT
-
Small size of metastatic lymph nodes with extracapsular spread greatly impacts treatment outcomes in oral squamous cell carcinoma patie...
-
Guidelines for inpatient admission after pediatric tonsillectomy have been proposed to improve the safety of this procedure. This study exam...
-
Publication date: Available online 14 May 2017 Source: Journal of Oral Biosciences Author(s): Hiromi Kimura-Suda, Teppi Ito BackgroundBo...
-
In metabolomics, thousands of substances can be detected in a single assay. This capacity motivates the development of metabolomics testing,...
-
Resistance to cancer chemotherapies leads to deadly consequences, yet current research focuses only on the roles of somatically acquired mut...
-
RT @ecancer_espanol : Abiraterone for metastatic, hormone sensitive, prostate cancer https://t.co/xa9jVlFrCg https://t.co/dj5XAacWCF fro...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου